Shareholder Rights Plan
Quick Facts
- Common name: Poison pill
- Purpose: Defensive mechanism against hostile takeovers
- Trigger: Typically 15-20% ownership threshold
- Duration: Usually 1-3 years with renewal options
- Legal status: Upheld by Delaware courts (1985)
A shareholder rights plan (commonly called a "poison pill") is a defensive mechanism that allows existing shareholders to purchase additional shares at a discount if any single shareholder acquires more than a specified percentage of the company's stock. It's the most common and effective hostile takeover defense.
In Plain English
A shareholder rights plan makes hostile takeovers prohibitively expensive. If an unwanted acquirer crosses the ownership threshold (usually 15-20%), every other shareholder gets the right to buy shares at half price. This massively dilutes the hostile bidder's stake, making the takeover economically impossible without board approval.
How It Works
The Mechanics
- Board adopts plan: Rights issued to all shareholders
- Rights attached to shares: Trade along with common stock
- Trigger threshold set: Usually 15-20% ownership
- Hostile acquirer crosses threshold: Rights become exercisable
- Flip-in feature activates: All shareholders except the acquirer can buy shares at 50% discount
- Acquirer's stake diluted: Takeover becomes uneconomic
Flip-In vs. Flip-Over
Flip-In Right:
- Shareholders can buy target's shares at discount
- Dilutes acquirer's stake in target
- Most common feature
Flip-Over Right:
- If target is merged into acquirer
- Shareholders can buy acquirer's shares at discount
- Protects against back-end squeeze-out
Typical Terms
| Feature | Standard Provision |
|---|---|
| Trigger threshold | 15-20% |
| Discount | 50% of market price |
| Duration | 1-3 years (renewable) |
| Redemption price | Nominal ($0.001 per right) |
| Board discretion | Can waive for friendly deals |
| Shareholder vote | Typically not required |
Types of Pills
Traditional Poison Pill
- Standard trigger (15-20%)
- Designed for hostile takeover defense
- Duration: 1-3 years
Low-Trigger Pill (COVID Pills)
- Lower threshold (5-10%)
- Deployed during market volatility
- Prevents opportunistic accumulation
- Gained popularity in 2020
Net Operating Loss (NOL) Pill
- Very low trigger (4.9%)
- Protects tax assets
- Prevents ownership change under IRC Section 382
- Courts more accepting of lower threshold
Dead Hand / Slow Hand Pills
- Only continuing directors can redeem
- Limits new board's ability to remove
- Highly controversial
- Struck down in some jurisdictions
Famous Shareholder Rights Plans
Netflix (2012)
When Carl Icahn accumulated a 10% stake, Netflix adopted a pill with a 10% trigger to prevent further accumulation without board engagement.
Twitter (2022)
After Elon Musk disclosed a 9.2% stake, Twitter's board adopted a pill with a 15% trigger. Musk eventually negotiated with the board for the $54.20/share acquisition.
Airgas (2011)
Airgas maintained its poison pill for over a year despite Air Products' hostile bid and shareholder support for the deal—upheld by Delaware courts as valid board discretion.
Legal Framework
Delaware Validation
Moran v. Household International (1985) established:
- Boards can adopt pills without shareholder approval
- Pills are valid exercise of business judgment
- Part of directors' fiduciary duty toolkit
Continuing Judicial Support
Airgas (2011) confirmed:
- Boards can "just say no" to hostile offers
- Pills can be maintained even against shareholder wishes
- Board's duty is to shareholders, not individual bidders
Limits on Pills
Courts have struck down:
- "Dead hand" pills (only certain directors can redeem)
- Pills adopted solely to entrench management
- Pills with unreasonably low triggers (except NOL pills)
Strategic Considerations
For Target Boards
Benefits:
- Forces negotiation with the board
- Provides time to find alternatives
- Protects against opportunistic bids
- Can be removed for friendly deals
Drawbacks:
- Institutional investors may oppose
- Proxy advisors often recommend against
- May suppress legitimate premium offers
- Creates entrenchment perception
For Potential Acquirers
Pills don't make takeovers impossible—they force acquirers to:
- Negotiate with the board
- Launch proxy fight to replace directors
- Wait for pill expiration
- Make offers compelling enough that board removes pill
Institutional Investor Views
Many institutional investors oppose pills:
- ISS: Generally recommends against unless short-term and justified
- Glass Lewis: Similar opposition to long-term pills
- BlackRock/Vanguard: Often vote against pill ratification
Companies increasingly submit pills to shareholder vote, and many are rejected.
"Shelf" Pills vs. Active Pills
Active Pill:
- Currently in effect
- Rights issued and ready to trigger
Shelf Pill:
- Prepared but not adopted
- Can be implemented quickly if threat emerges
- Increasingly common approach
Most large companies have a shelf pill ready for rapid deployment.
Practical Takeaways
For target companies: Shareholder rights plans remain the most effective takeover defense. Keep a shelf pill ready. If adopted, expect institutional investor scrutiny—be prepared to explain the specific threat and limited duration.
For potential acquirers: Don't expect to bypass the board. A pill means you must either negotiate a friendly deal or wage a proxy fight to replace directors who will redeem the pill. Plan for a longer, more expensive process.
Related Reading
- Poison Pill — Same defense, different name
- Hostile Takeover — What shareholder rights plans defend against
- Proxy Fight — How acquirers circumvent pills
- Staggered Board — Defense that strengthens pill effectiveness